J R Schofield|W A Robinson - JoVE Visualize

Showing results (151-160 of 169) with videos related to

Pageof 17

Sort By:

Scientific Reports|September 23, 2017

Structural properties of thin-film ferromagnetic topological insulatorsC L Richardson, J M Devine-Stoneman, G Divitini, et al.

Clinical Nuclear Medicine|May 1, 1989

Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.

Burns, Including Thermal Injury|June 1, 1985

Early vascular grafting to prevent upper extremity necrosis after electrical burns. Commentary on indications for surgeryX W Wang, B B Roberts, R L Zapata-Sirvent, et al.

Nano Letters|November 29, 2013

Electric-field control of ferromagnetism in a nanocomposite via a ZnO phaseThomas Fix, Eun-Mi Choi, Jason W A Robinson, et al.

The Journal of Physical Chemistry Letters|May 22, 2023

Modification of Weak Localization in Metallic Thin Films Due to the Adsorption of Chiral MoleculesMeital Ozeri, Jiahui Xu, Gilad Bauer, et al.

Scientific Reports|July 23, 2016

Magnetic coupling at rare earth ferromagnet/transition metal ferromagnet interfaces: A comprehensive study of Gd/NiT D C Higgs, S Bonetti, H Ohldag, et al.

Cancer|January 1, 1995

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.

Scientific Reports|October 13, 2017

Photonic Sorting of Aligned, Crystalline Carbon Nanotube TextilesJohn S Bulmer, Thurid S Gspann, Francisco Orozco, et al.

Physical Review Letters|May 27, 2022

Parametric Amplifiers Based on Quantum DotsLaurence Cochrane, Theodor Lundberg, David J Ibberson, et al.

Journal of the American College of Surgeons|July 11, 1998

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trialM K Wallack, M Sivanandham, C M Balch, et al.

Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:

Pageof 17

Scientific Reports|September 23, 2017

Structural properties of thin-film ferromagnetic topological insulatorsC L Richardson, J M Devine-Stoneman, G Divitini, et al.

Clinical Nuclear Medicine|May 1, 1989

Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.

Burns, Including Thermal Injury|June 1, 1985

Early vascular grafting to prevent upper extremity necrosis after electrical burns. Commentary on indications for surgeryX W Wang, B B Roberts, R L Zapata-Sirvent, et al.

Nano Letters|November 29, 2013

Electric-field control of ferromagnetism in a nanocomposite via a ZnO phaseThomas Fix, Eun-Mi Choi, Jason W A Robinson, et al.

The Journal of Physical Chemistry Letters|May 22, 2023

Modification of Weak Localization in Metallic Thin Films Due to the Adsorption of Chiral MoleculesMeital Ozeri, Jiahui Xu, Gilad Bauer, et al.

Scientific Reports|July 23, 2016

Magnetic coupling at rare earth ferromagnet/transition metal ferromagnet interfaces: A comprehensive study of Gd/NiT D C Higgs, S Bonetti, H Ohldag, et al.

Cancer|January 1, 1995

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.

Scientific Reports|October 13, 2017

Photonic Sorting of Aligned, Crystalline Carbon Nanotube TextilesJohn S Bulmer, Thurid S Gspann, Francisco Orozco, et al.

Physical Review Letters|May 27, 2022

Parametric Amplifiers Based on Quantum DotsLaurence Cochrane, Theodor Lundberg, David J Ibberson, et al.

Journal of the American College of Surgeons|July 11, 1998

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trialM K Wallack, M Sivanandham, C M Balch, et al.

Pageof 17